Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+1.06M
-
Total reported value, excl. options
-
$51.2M
-
Value change
-
+$4.98M
-
Put/Call ratio
-
0.65
-
Number of buys
-
24
-
Number of sells
-
-19
-
Price
-
$4.65
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2019
66 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2019.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 79.8M outstanding shares and own 13.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.24M shares), VANGUARD GROUP INC (1.76M shares), ICONIQ Capital, LLC (1.71M shares), Tieton Capital Management, LLC (1.32M shares), Uniplan Investment Counsel, Inc. (705K shares), STATE STREET CORP (583K shares), GEODE CAPITAL MANAGEMENT, LLC (418K shares), NORTHERN TRUST CORP (417K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (268K shares), and UBS Group AG (194K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.